RANDOMIZED, DOUBLE-BLIND, PHASE 2/3 STUDY OF IV AMISULPRIDE AS PREVENTION OF POST-OPERATIVE NAUSEA AND VOMITING IN PEDIATRIC PATIENTS

Registry ID

DP10027

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE2

Study type

INTERVENTIONAL

Sponsor

ACACIA PHARMA LTD

Start date

2023-06-05

Last update

2023-02-22

Conditions

• NAUSEA AND VOMITING

Related clinical trials

• ADDING APREPITANT TO A MULTIMODAL STRATEGY FOR PREVENTING POSTOPERATIVE NAUSEA AND VOMITING IN HIGH-RISK PATIENTS UNDERGOING OUTPATIENT SURGERY
• A RANDOMIZED CONTROLLED TRIAL COMPARING APREPITANT TO STANDARD OF CARE FOR POSTOPERATIVE NAUSEA AND VOMITING PROPHYLAXIS IN CHILDREN UNDERGOING SCOLIOSIS SURGERY: THE APRE-PONV TRIAL
• RANDOMIZED CONTROLLED TRIAL OF OLANZAPINE FOR THE CONTROL OF CHEMOTHERAPY-INDUCED VOMITING IN CHILDREN RECEIVING CHEMOTHERAPY FOR HEMATOPOIETIC STEM CELL TRANSPLANT CONDITIONING

View on source registry